The prediction of plasma and brain levels of 2,3,5,6-tetramethylpyrazine following transdermal application

Journal Title: The AAPS Journal - Year 2002, Vol 4, Issue 4

Abstract

The purpose of this study was to construct a pharmacokinetic (PK) model and to determine PK parameters of 2,3,5,6-tetramethylpyrazine (TMP) after application of TMP transdermal delivery system. Data were obtained in Sprague-Dawley (SD) rats following a single dose of TMP transdermal delivery system. Blood samples were obtained at 0, 0.25, 0.5, 1, 2, 4, 6, 16, and 24 hours after the transdermal application. In the brain level study, 18 SD rats were divided into 6 groups. Three SD rats before and after transdermal application were culled and sacrificed at each of the following time intervals: 2, 4, 6, 16, and 24 hours after the TMP-TTS application. TMP concentrations in plasma and brain tissues were determined using high performance liquid chromatography and data were fitted using a zero-order absorption and a firstorder-elimination 3-compartment PK model. Fitted parameters included 2 volumes of distribution (V1, V2) and 2 elimination rate constants (k10, k20). The elimination half-life for TMP in plasma and brain was 26.5 and 31.2 minutes, respectively. The proposed PK model fit observed concentrations of TMP very well. This model is useful for predicting drug concentrations in plasma and brain and for assisting in the development of transdermal systems.

Authors and Affiliations

Xiaohong Qi, Chrisita Ackermann, Duxin Sun, Rong (Ron) Liu, Minli Sheng, Huimin Hou

Keywords

Related Articles

Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice

Drug treatment poses a therapeutic challenge in cystic fibrosis (CF) because the disposition of a number of drugs is altered in CF. Enhanced clearance of acetaminophen (APAP) and indocyanine green (ICG) have previously b...

Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Biotherapeutics for Autoimmune and Inflammatory Conditions

Biotherapeutics are becoming an increasingly common drug class used to treat autoimmune and other inflammatory conditions. Optimization of absorption, distribution, metabolism, and excretion (ADME) profiles of biotherape...

Use of Dried Blood Spots in Drug Development: Pharmacokinetic Considerations

Dried blood spots are increasingly being used in drug development. This commentary considers the pharmacokinetic issues that arise and compares these with those attached to plasma, the mainstay matrix. A common implicit...

A thermogravimetric analysis of non-polymeric pharmaceutical plasticizers: Kinetic analysis, method validation, and thermal stability evaluation

Four non-polymeric plasticizers, propylene glycol, diethyl phthalate, triacetin, and glycerin have been subjected to rising temperature thermogravimetry for kinetic analysis and vaporization-based thermal stability evalu...

Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies

The online version of this article (doi:10.1208/s12248-014-9596-5) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP682052
  • DOI  10.1208/ps040446
  • Views 103
  • Downloads 0

How To Cite

Xiaohong Qi, Chrisita Ackermann, Duxin Sun, Rong (Ron) Liu, Minli Sheng, Huimin Hou (2002). The prediction of plasma and brain levels of 2,3,5,6-tetramethylpyrazine following transdermal application. The AAPS Journal, 4(4), -. https://europub.co.uk/articles/-A-682052